PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32234375-0	2020	NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.	Docetaxel	15-24	NPR2 like, GATOR1 complex subunit	Homo sapiens	0-5	
32234375-6	2020	We found that NPRL2 was significantly overexpressed in docetaxel-resistant CRPC cells, while autophagy was enhanced and mTOR signaling was inhibited.	Docetaxel	55-64	NPR2 like, GATOR1 complex subunit	Homo sapiens	14-19	
32234375-7	2020	Inhibiting NPRL2 increased the sensitivity to docetaxel in docetaxel-resistant CRPC cells, enhanced apoptosis and inhibited autophagy, and the opposite trends were observed when the mTOR inhibitor torin 1 was added to NPRL2-silenced cells.	Docetaxel	46-55	NPR2 like, GATOR1 complex subunit	Homo sapiens	11-16	
32234375-7	2020	Inhibiting NPRL2 increased the sensitivity to docetaxel in docetaxel-resistant CRPC cells, enhanced apoptosis and inhibited autophagy, and the opposite trends were observed when the mTOR inhibitor torin 1 was added to NPRL2-silenced cells.	Docetaxel	59-68	NPR2 like, GATOR1 complex subunit	Homo sapiens	11-16	
32234375-8	2020	We further found that NPRL2 silenced docetaxel-resistant CRPC cells were sensitive to docetaxel in vivo.	Docetaxel	37-46	NPR2 like, GATOR1 complex subunit	Homo sapiens	22-27	
32234375-8	2020	We further found that NPRL2 silenced docetaxel-resistant CRPC cells were sensitive to docetaxel in vivo.	Docetaxel	86-95	NPR2 like, GATOR1 complex subunit	Homo sapiens	22-27